QUATRALE, ANNA ELISA
 Distribuzione geografica
Continente #
NA - Nord America 439
EU - Europa 77
AS - Asia 14
OC - Oceania 1
Totale 531
Nazione #
US - Stati Uniti d'America 438
SE - Svezia 31
IT - Italia 17
BE - Belgio 14
CN - Cina 12
GB - Regno Unito 10
FI - Finlandia 2
AU - Australia 1
CA - Canada 1
DE - Germania 1
FR - Francia 1
IN - India 1
SG - Singapore 1
UA - Ucraina 1
Totale 531
Città #
Fairfield 66
Chandler 62
Woodbridge 43
Cambridge 32
Ann Arbor 27
Ashburn 25
Nyköping 24
Houston 23
Seattle 23
Wilmington 22
Bari 14
Brussels 14
Brooklyn 7
Lawrence 7
Roxbury 7
Beijing 6
Falls Church 4
Miami 4
Monmouth Junction 4
Des Moines 3
Jacksonville 3
Jiaxing 2
Los Angeles 2
New York 2
Boardman 1
Brindisi 1
Canberra 1
Clifton 1
Hounslow 1
Indiana 1
Jinan 1
London 1
Markham 1
Nanjing 1
Norwalk 1
Paris 1
Prescot 1
Princeton 1
San Diego 1
San Francisco 1
Santa Clara 1
Shenyang 1
Singapore 1
Tappahannock 1
Tianjin 1
Washington 1
Totale 448
Nome #
null 86
EGFR tyrosine kinases inhibitors in cancer treatment: in vitro and in vivo evidence 80
The coordinated role of CYP450 enzymes and P-gp in determining cancer resistance to chemotherapy 78
Synthetic lethality to overcome cancer drug resistance 76
Optimize radiochemotherapy in pancreatic cancer: PARP inhibitors a new therapeutic opportunity 72
MC70 potentiates doxorubicin efficay in colon and breast cancer in vitro treatment 62
Anti-EGFR monoclonal antibody in cancer treatment: In vitro and in vivo evidence 61
Hepatic stellate cells induce hepatocellular carcinoma cell resistance to sorafenib through the laminin-332/α3 integrin axis recovery of focal adhesion kinase ubiquitination 31
Totale 546
Categoria #
all - tutte 2.413
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.413


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020148 4 0 2 2 28 14 15 22 32 7 14 8
2020/202174 6 15 3 1 6 9 4 7 6 10 6 1
2021/2022105 3 20 1 3 16 10 5 7 6 2 10 22
2022/2023140 11 22 7 26 6 22 1 11 29 0 0 5
2023/202437 7 4 2 2 4 7 1 3 4 2 0 1
2024/20256 6 0 0 0 0 0 0 0 0 0 0 0
Totale 546